Authors: Grabar, S Pradier, C Le Corfec, E Lancar, R Allavena, C Bentata, M Berlureau, P Dupont, C Fabbro-Peray, P Poizot-Martin, I Costagliola, D

Citation: S. Grabar et al., Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor, AIDS, 14(2), 2000, pp. 141-149

Authors: Saint-Marc, T Partisani, M Poizot-Martin, I Rouviere, O Bruno, F Avellaneda, R Lang, JM Gastaut, JA Touraine, JL

Citation: T. Saint-marc et al., Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study, AIDS, 14(1), 2000, pp. 37-49

Authors: Tamalet, C Pasquier, C Yahi, N Colson, P Poizot-Martin, I Lepeu, G Gallais, H Massip, P Puel, J Izopet, J

Citation: C. Tamalet et al., Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection, J MED VIROL, 61(2), 2000, pp. 181-186

Authors: Tamalet, C Yahi, N Tourres, C Colson, P Quinson, AM Poizot-Martin, I Dhiver, C Fantini, J

Citation: C. Tamalet et al., Multidrug resistance genotypes (insertions in the beta 3-beta 4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: Incidence and association with other resistance mutations, VIROLOGY, 270(2), 2000, pp. 310-316

Authors: Saint-Marc, T Partisani, M Poizot-Martin, I Bruno, F Rouviere, O Lang, JM Gastaut, JA Touraine, JL

Citation: T. Saint-marc et al., A syndrome of peripheral fat wasting (lipodystrophy) in patients receivinglong-term nucleoside analogue therapy, AIDS, 13(13), 1999, pp. 1659-1667